BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang Q, Lou Y, Bai XL, Liang TB. Intratumoral heterogeneity of hepatocellular carcinoma: From single-cell to population-based studies. World J Gastroenterol 2020; 26(26): 3720-3736 [PMID: 32774053 DOI: 10.3748/wjg.v26.i26.3720]
URL: https://www.wjgnet.com/1948-5182/full/v26/i26/3720.htm
Number Citing Articles
1
Jérôme Ghidaglia, Nicolas Golse, Alina Pascale, Mylène Sebagh, Florent L. Besson. 18F-FDG /18F-Choline Dual-Tracer PET Behavior and Tumor Differentiation in HepatoCellular Carcinoma. A Systematic ReviewFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.924824
2
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular CarcinomaCancers 2022; 14(16): 4051 doi: 10.3390/cancers14164051
3
Dirk Andreas Ridder, Arndt Weinmann, Mario Schindeldecker, Lana Louisa Urbansky, Kristina Berndt, Tiemo Sven Gerber, Hauke Lang, Johannes Lotz, Karl J. Lackner, Wilfried Roth, Beate Katharina Straub. Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinomaInternational Journal of Cancer 2022; 150(6): 1053 doi: 10.1002/ijc.33898
4
N. Ivanenko. BIOFILM AND TUMOR: INTERPRETATION OF INTERACTION AND TREATMENT STRATEGIES. ReviewMedical Science of Ukraine (MSU) 2021; 17(1): 104 doi: 10.32345/2664-4738.1.2021.13
5
Valli De Re, Anna Rossetto, Alessandro Rosignoli, Elena Muraro, Vito Racanelli, Maria Lina Tornesello, Aron Zompicchiatti, Alessandro Uzzau. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and PrognosisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.897703
6
Mudassier Ahmad, Anupam Dhasmana, Prateek Suresh Harne, Asif Zamir, Bilal Bin Hafeez. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?Seminars in Cancer Biology 2022;  doi: 10.1016/j.semcancer.2022.02.015
7
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary CancersTrends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
8
Rengul Cetin-Atalay, Deniz Cansen Kahraman, Esra Nalbat, Ahmet Sureyya Rifaioglu, Ahmet Atakan, Ataberk Donmez, Heval Atas, M. Volkan Atalay, Aybar C. Acar, Tunca Doğan. Data Centric Molecular Analysis and Evaluation of Hepatocellular Carcinoma Therapeutics Using Machine Intelligence-Based ToolsJournal of Gastrointestinal Cancer 2021; 52(4): 1266 doi: 10.1007/s12029-021-00768-x
9
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturityJHEP Reports 2022; 4(8): 100498 doi: 10.1016/j.jhepr.2022.100498
10
Mengchao Wei, Manxia Lin, Xian Zhong, Zihao Dai, Shunli Shen, Shaoqiang Li, Zhenwei Peng, Ming Kuang. Role of Preoperational Imaging Traits for Guiding Treatment in Single ≤ 5 cm Hepatocellular CarcinomaAnnals of Surgical Oncology 2022; 29(8): 5144 doi: 10.1245/s10434-022-11344-3
11
Samer Tohme, Hamza O Yazdani, Amaan Rahman, Sanah Handu, Sidrah Khan, Tanner Wilson, David A Geller, Richard L Simmons, Michele Molinari, Christof Kaltenmeier, José L. Mauriz. The Use of Machine Learning to Create a Risk Score to Predict Survival in Patients with Hepatocellular Carcinoma: A TCGA Cohort AnalysisCanadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/5212953
12
Begum Dariya, Sujatha Peela, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma2022; : 1 doi: 10.1016/B978-0-323-98806-3.00001-5
13
Nwamaka Iloani, Areeba Hafeez, Serena Bao, Victoria Dulemba, Christoffer Lambring, Umesh T. Sankpal, Riyaz Basha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 22022; : 185 doi: 10.1016/B978-0-323-98807-0.00013-2